Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04223830 · ClinicalTrials.gov registry record · NA
Initial Case Series With Exalt Single-Use Duodenoscope - Expanded User Experience
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT04223830 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 200 participants.
The verdict
NCT04223830, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The objective of this study is to confirm procedural performance of the Exalt Model D Single-Use Duodenoscope in Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and other duodenoscope-based procedures.
Interventions
- DEVICE Exalt Model D Single-Use Duodenoscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2020-01-14 |
| Est. Completion | 2021-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04223830
The ClinicalTrials.gov registry entry for NCT04223830 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exalt Model D Single-Use Duodenoscope is the first listed.
NCT04223830 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04223830 about?
NCT04223830 is a clinical study titled "Initial Case Series With Exalt Single-Use Duodenoscope - Expanded User Experience". The objective of this study is to confirm procedural performance of the Exalt Model D Single-Use Duodenoscope in Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and other duodenoscope-based procedures.
What is the current status of trial NCT04223830?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2020-01-14. Estimated completion is 2021-03-01.
What interventions are being tested in trial NCT04223830?
The interventions under investigation include: Exalt Model D Single-Use Duodenoscope (DEVICE).
Who is sponsoring clinical trial NCT04223830?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.